An evaluation of the risk factors of breast cancer in women in Ilam Province: a case–control study based on hospital

IF 0.4 Q4 ONCOLOGY

Breast Cancer Management Pub Date : 2020-12-01 DOI:10.2217/bmt-2020-0026

S. Rahmati, M. Azami, Z. Jaafari, Nasrin Pouratar, Khairollah Asodollahi

引用次数: 1

Abstract

Aims: The present study aimed to identify the most associated risk factors of breast cancer in Ilam province in 2015–2016. Materials & methods: In this case–control study, the case group consisted of 50 women with breast cancer with a definitive diagnosis from date 23 September 2015 to 22 September 2016. The two groups were group matched in terms of age. Data were collected through interviews and medical records. Results: According to the results, there was a significant relationship between the disease status and variables of family history, history of irregular menstrual cycles, history of breastfeeding, menopausal status, history of oral contraceptive pill consumption, BMI, menarche and number of pregnancies (p < 0.05). Conclusion: Regarding decisive risk factors of breast cancer, more studies with larger sample sizes that take into account more risk factors are necessary.

查看原文本刊更多论文

伊兰省女性癌症危险因素评估：基于医院的病例对照研究

目的:本研究旨在确定2015-2016年伊拉姆省乳腺癌最相关的危险因素。材料与方法:在本病例对照研究中，病例组包括2015年9月23日至2016年9月22日确诊的50名乳腺癌妇女。这两组在年龄上是分组匹配的。通过访谈和医疗记录收集数据。结果:家族史、月经周期不规律史、母乳喂养史、绝经状况、口服避孕药史、BMI、月经初潮、怀孕次数等变量与疾病状态有显著相关(p < 0.05)。结论:对于乳腺癌的决定性危险因素，需要更多更大样本量的研究，考虑更多的危险因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Breast Cancer Management ONCOLOGY-

CiteScore

0.60

自引率

0.00%

发文量

审稿时长

13 weeks

期刊介绍： Breast Cancer Management (ISSN: 1758-1923) addresses key issues in disease management by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. The journal also highlights significant advances in basic and translational research, and places them in context for future therapy. Breast Cancer Management provides oncologists and other health professionals with the latest findings and opinions on reducing the burden of this widespread disease. Recent research findings and advances clinical practice in the field are reported and analyzed by international experts. The journal presents this information in clear, accessible formats. All articles are subject to independent review by a minimum of three independent experts. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal’s Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3. Coverage includes: Diagnosis and imaging, Surgical approaches, Radiotherapy, Systemic therapies, Cancer clinical trials, Genetic aspects of disease, Personalized medicine, Translational research and biomarker studies, Management of psychological distress, Epidemiological studies, Pharmacoeconomics, Evidence-based treatment guidelines.